Description

Ribavirin USP

Ribavirin USP is a high-purity, broad-spectrum antiviral nucleoside analog used in pharmaceutical formulations for the treatment of RNA and DNA viral infections. Compliant with United States Pharmacopeia (USP) standards, it inhibits viral RNA synthesis and viral replication, making it a key therapeutic agent in combination regimens for chronic hepatitis, respiratory syncytial virus, and other viral diseases. Ribavirin
• Is a USP-compliant antiviral nucleoside analog for pharmaceutical use
• Is used in oral capsules, tablets, and intravenous formulations
• Inhibits viral RNA synthesis and replication
• Is suitable for acute and chronic viral infection management
• Is manufactured under Good Manufacturing Practice (GMP) certified conditions
• Is supplied with complete regulatory documentation including Certificate of Analysis (CoA) and technical data
Ribavirin is chemically designated as 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide. It appears as a white to off-white crystalline powder that is highly soluble in water and compatible with oral and parenteral dosage forms.
In pharmaceutical applications, Ribavirin USP is used in:
• Oral capsules and tablets for chronic hepatitis C therapy in combination with other antivirals
• Intravenous formulations for severe respiratory syncytial virus infections
• Compounded antiviral preparations for research or specialized indications
• Combination therapies targeting multiple RNA viruses
• Clinical studies and emergency antiviral treatment protocols
Ribavirin functions as a nucleoside analog, incorporating into viral RNA and interfering with replication. Its broad-spectrum activity and well-characterized pharmacokinetics make it suitable for both monotherapy and combination regimens under medical supervision.
CarboMer supplies Ribavirin USP with control over assay, particle size, residual solvents, and microbial purity. Each batch meets USP monograph standards and is suitable for regulated pharmaceutical applications.
The material is packaged in sealed, moisture-resistant, tamper-evident containers. Available in laboratory, pilot, and commercial-scale quantities. Minimum order quantities (MOQ), lead times, and documentation including CoA and SDS are provided upon request.
Each batch is tested for identity (IR, HPLC), assay, water content, residual solvents, heavy metals, and microbial limits. Certificates of Analysis (CoA), Safety Data Sheets (SDS), and full traceability documentation accompany every shipment.
As with all CarboMer antiviral APIs, Ribavirin USP is supported by formulation guidance, regulatory expertise, and secure global supply to ensure safe, effective, and compliant pharmaceutical products.